UBS Maintains Buy on Danaher, Lowers Price Target to $305
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Dan Leonard maintains a Buy rating on Danaher (NYSE:DHR) but lowers the price target from $309 to $305.
October 23, 2024 | 3:56 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst Dan Leonard continues to recommend buying Danaher shares, though he slightly reduces the price target from $309 to $305, indicating a modest adjustment in expected valuation.
The Buy rating suggests continued confidence in Danaher's performance, but the slight reduction in price target indicates a minor adjustment in expected valuation. This may not significantly impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100